• Safe therapeutic measures for Mucha-Habermann's disease in children are lacking. Three patients with the disease were treated with erythromycin for systemic effect. Although the series is small and uncontrolled, this approach seemed effective. An anti-inflammatory mechanism related to inhibition of chemotaxis is speculated.
(Arch Dermatol 114:1679-1680, 1978)
Shavin JS, Jones TM, Aton JK, Abele DC, Smith JG. Mucha-Habermann's Disease in Children: Treatment With Erythromycin. Arch Dermatol. 1978;114(11):1679–1680. doi:10.1001/archderm.1978.01640230053014
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: